Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.
Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.
24-Jun-2022
14-Jun-2022
14-Jun-2022
13-Jun-2022
13-Jun-2022